|
BCN4331 |
N-trans-Feruloyl-3-methoxytyramine
|
|
1. N-trans-Feruloyl-3-methoxytyramine shows significantly DPPH radical scavenging activities. |
|
BCN4337 |
2',3,5,6',7-Pentahydroxyflavanone
|
|
1. (2R,3R)-2',3,5,6'7-pentahydroxyflavanone(2',3,5,6',7-Pentahydroxyflavanone) can inhibit the histamine release from rat mast cells induced by compound 48/80.
2. (2R,3R)-2',3,5,6'7-pentahydroxyflavanone inhibits the lipid peroxide formation by Feand ascorbic acid, it also inhibits the lipid peroxide formation induced by adenosine diphosphate and reduces nicotinamide adenine dinucleotide phosphate in rat liver homogenate. |
|
BCN4345 |
2',5,6',7-Tetrahydroxyflavanone
|
|
1. (2S)-2',5,6',7-Tetrahydroxyflavanone can inhibit the lipid peroxide formation induced by adenosine diphosphate and reduced nicotinamide adenine dinucleotide phosphate in rat liver homogenate. |
|
BCN4373 |
Ethyl gallate
|
|
Ethyl gallate has anti-cancer, antioxidant activities, it may be an alternative class of vasopressors for use in septic shock. Ethyl gallate can treat acute lung injury (ALI) mainly by reducing the total cells and infiltration of activated polymorphonuclear leukocytes (PMNs). Ethyl gallate inhibits Akt , NF-κB p-65, Bcl-2/Bax, and mRNA levels of MMP-2 and MMP-9. |
|
BCN4376 |
Stigmasterol
|
|
Stigmasterol is used as a precursor in the manufacture of synthetic progesterone, it is an antagonist of the bile acid nuclear receptor FXR, which has anti-inflammatory, thyroid inhibitory, cholesterol-lowering, antiperoxidative and hypoglycemic effects; it has indicated that stigmasterol may be useful in prevention of certain cancers, including ovarian, prostate, breast, and colon cancers. Stigmasterol inhibits the NF-kappaB pathway. |
